|
151 |
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma Enthalten in Blood cancer journal Bd. 11, 7.1.2021, Nr. 1, date:1.2021: 1-10
|
|
|
152 |
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma Enthalten in BMC cancer Bd. 16, 25.4.2016, Nr. 1, date:12.2016: 1-10
|
|
|
153 |
Somatostatin receptor subtype 2 (sst2) is a potential prognostic marker and a therapeutic target in medulloblastoma Enthalten in Child's nervous system Bd. 29, 16.5.2013, Nr. 8, date:8.2013: 1253-1262
|
|
|
154 |
The chemokines CCR1 and CCRL2 have a role in colorectal cancer liver metastasis Enthalten in Tumor biology Bd. 37, 18.9.2015, Nr. 2, date:2.2016: 2461-2471
|
|